22-016434 the laboratory of vascular inflammation and thrombosis (LVTI) within the translational vascular medicine branch (TVMB) is currently in need of an ibidi in vitro flow chamber perfusion…

Ended Purchase Order Awarded

Contract number
75N92022P00301
Awardee
Awarding agency
Obligated
$21,475

Award facts

Contract value 100% obligated
$21,475.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Madison, WI 53719, USA

Award details come from SAM.gov/FPDS.

About this award

The National Heart Lung and Blood Institute awarded a purchase order to Ibidi USA Inc. for $21,475.00 on August 26, 2022, to procure an Ibidi in vitro flow chamber perfusion system for the Laboratory of Vascular Inflammation and Thrombosis within the Translational Vascular Medicine Branch. The order carries no set-aside designation and is firm fixed price. Place of performance is Madison, Wisconsin. The order is due for completion September 30, 2022.

Description

22-016434 the laboratory of vascular inflammation and thrombosis (LVTI) within the translational vascular medicine branch (TVMB) is currently in need of an ibidi in vitro flow chamber perfusion system.

Quick answers

Who was awarded contract 75N92022P00301?

75N92022P00301 was awarded to Ibidi USA Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 26, 2022.

How much is contract 75N92022P00301 worth?

The government has obligated $21,475 on 75N92022P00301.

Was contract 75N92022P00301 competed?

The extent of competition for 75N92022P00301 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award